Literature DB >> 30006892

Terlipressin or norepinephrine, or both in septic shock?

Johan Mårtensson1,2, Anthony C Gordon3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30006892     DOI： 10.1007/s00134-018-5290-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  14 in total

1.  Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis.

Authors:  Roeland F Stolk; Tom van der Poll; Derek C Angus; Johannes G van der Hoeven; Peter Pickkers; Matthijs Kox
Journal:  Am J Respir Crit Care Med       Date:  2016-09-01       Impact factor: 21.405

2.  A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock.

Authors:  Ashok Choudhury; Chandan K Kedarisetty; Chitranshu Vashishtha; Deepak Saini; Sachin Kumar; Rakhi Maiwall; Manoj K Sharma; Ajeet S Bhadoria; Guresh Kumar; Yogendra K Joshi; Shiv K Sarin
Journal:  Liver Int       Date:  2016-10-20       Impact factor: 5.828

3.  Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.

Authors:  Anthony C Gordon; Alexina J Mason; Neeraja Thirunavukkarasu; Gavin D Perkins; Maurizio Cecconi; Magda Cepkova; David G Pogson; Hollmann D Aya; Aisha Anjum; Gregory J Frazier; Shalini Santhakumaran; Deborah Ashby; Stephen J Brett
Journal:  JAMA       Date:  2016-08-02       Impact factor: 56.272

4.  NOREPINEPHRINE: NOT TOO MUCH, TOO LONG.

Authors:  Claude Martin; Sophie Medam; François Antonini; Julie Alingrin; Malik Haddam; Emmanuelle Hammad; Bertrand Meyssignac; Coralie Vigne; Laurent Zieleskiewicz; Marc Leone
Journal:  Shock       Date:  2015-10       Impact factor: 3.454

Review 5.  Vasopressin in vasodilatory and septic shock.

Authors:  James A Russell
Journal:  Curr Opin Crit Care       Date:  2007-08       Impact factor: 3.687

6.  A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome.

Authors:  Arun J Sanyal; Thomas Boyer; Guadalupe Garcia-Tsao; Frederick Regenstein; Lorenzo Rossaro; Beate Appenrodt; Andres Blei; Veit Gülberg; Samuel Sigal; Peter Teuber
Journal:  Gastroenterology       Date:  2008-02-13       Impact factor: 22.682

7.  Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock.

Authors:  Sebastian Rehberg; Christian Ertmer; Gabriele Köhler; Hans-Ulrich Spiegel; Andrea Morelli; Matthias Lange; Katharina Moll; Katrin Schlack; Hugo Van Aken; Fuhong Su; Jean-Louis Vincent; Martin Westphal
Journal:  Intensive Care Med       Date:  2009-04-10       Impact factor: 17.440

8.  Vasopressin versus norepinephrine infusion in patients with septic shock.

Authors:  James A Russell; Keith R Walley; Joel Singer; Anthony C Gordon; Paul C Hébert; D James Cooper; Cheryl L Holmes; Sangeeta Mehta; John T Granton; Michelle M Storms; Deborah J Cook; Jeffrey J Presneill; Dieter Ayers
Journal:  N Engl J Med       Date:  2008-02-28       Impact factor: 91.245

9.  Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study.

Authors:  A Morelli; C Ertmer; M Lange; M Dünser; S Rehberg; H Van Aken; P Pietropaoli; M Westphal
Journal:  Br J Anaesth       Date:  2008-02-27       Impact factor: 9.166

Review 10.  Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis.

Authors:  William F McIntyre; Kevin J Um; Waleed Alhazzani; Alexandra P Lengyel; Ludhmila Hajjar; Anthony C Gordon; François Lamontagne; Jeff S Healey; Richard P Whitlock; Emilie P Belley-Côté
Journal:  JAMA       Date:  2018-05-08       Impact factor: 56.272
View more
  5 in total

1.  Preliminary results of synergy between norepinephrine and terlipressin during septic shock.

Authors:  Gary Duclos; Michel Cantaloube; Sophie Medam; Noémie Resseguier; Marc Leone
Journal:  Intensive Care Med       Date:  2019-02-06       Impact factor: 17.440

2.  Focus on blood pressure targets and vasopressors in critically ill patients.

Authors:  Anders Perner; Peter B Hjortrup; Yaseen Arabi
Journal:  Intensive Care Med       Date:  2019-08-05       Impact factor: 17.440

3.  Terlipressin for septic shock patients: a meta-analysis of randomized controlled study.

Authors:  Yibing Zhu; Huibin Huang; Xiuming Xi; Bin Du
Journal:  J Intensive Care       Date:  2019-03-12

4.  Effects of Collagen Antibacterial Functional Dressing plus Continuous Nursing on Lower Extremity Skin Injury Caused by Norepinephrine in Patients with Septic Shock.

Authors:  Xiaoxia Hu; Hongxia Wang; Yun Lin
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-18       Impact factor: 2.650

5.  Efficacy and safety of vasopressin and terlipressin in preterm neonates: a protocol for a systematic review.

Authors:  Abdulrahman Salim Alsaadi; Katelyn Sushko; Vivian Bui; John Van Den Anker; Abdul Razak; Samira Samiee-Zafarghandy
Journal:  BMJ Paediatr Open       Date:  2021-06-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.